Abrale - Associação Brasileira De Câncer Do Sangue

What Abrale - Associação Brasileira De Câncer Do Sangue does

Abrale (Associação Brasileira de Câncer do Sangue) is a Brazilian nonprofit patient advocacy association that provides free services to people affected by blood cancers, including leukemia, lymphoma, and multiple myeloma, headquartered in São Paulo, Brazil. The organization operates as a registered civil society association with no disclosed equity funding or VC/PE backing; its core activities comprise patient navigation, education, awareness campaigns, and public policy advocacy on behalf of patients and families.

Its service offering is delivered free of charge and includes patient support lines, educational content, navigator programs that help patients access diagnosis and treatment, and targeted initiatives such as the pediatric oncology program Projeto Dodói. Abrale coordinates with Brazilian hematology and oncology institutions — including ABHH, TJCC, and INCA — and participates in international patient-advocacy coalitions, functioning as a structural link between patients, clinicians, and the public health system rather than as a clinical provider itself.

The business model is that of a Brazilian nonprofit association: revenue is generated through donations, corporate social investment, and partnerships rather than commercial pricing, with all patient-facing services offered at no cost. There is no disclosed headcount, audited revenue figure, or productized technology platform in the available data; the organization's value proposition rests on brand credibility, institutional relationships, and direct human-led patient support rather than on proprietary technology.

Name

Abrale - Associação Brasileira De Câncer Do Sangue

Legal name

Associação Brasileira de Câncer do Sangue

Website

https://abrale.org.br

Company type

Private

Founded year

2002

Operating status

Operating

Short description

Abrale is a Brazilian nonprofit association providing free patient advocacy, education, and navigation services to individuals and families affected by blood cancers across Brazil, headquartered in São Paulo.

Ownership category

akta.pro rank

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Individual and Corporate Donations: Abrale receives donations from individuals and corporations through its online donation platform and direct giving campaigns.
2. Social Investment: The organization receives social investment funding from companies and partners, documented through annual social balance reports.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Abrale is a Brazilian nonprofit civil association (associação civil sem fins lucrativos) founded in 2002 that delivers free patient support services to people diagnosed with blood cancers such as leukemia, lymphoma, and multiple myeloma. Its portfolio includes nutritional counseling, psychological support, legal guidance, teleconsultation, and structured patient navigation, alongside public policy and advocacy work aimed at improving access to diagnosis and treatment in Brazil.

Product overview

Abrale is a non-profit organization (Associação) that provides free support services to blood cancer patients in Brazil. The organization offers a comprehensive ecosystem of services including patient navigation, psychological support, nutritional counseling, legal guidance, teleconsultation (second opinion), patient communities, and educational projects. The portfolio includes specialized projects like Projeto Dodói (pediatric cancer support), Onco TeleInterconsulta (telemedicine), Onco Ensino (education), Observatório de Oncologia (data monitoring), and Movimento TJCC (advocacy coalition). The organization also maintains digital channels including TV Abrale (YouTube channel with weekly videos) and a free digital magazine. These services collectively support patients with various blood cancers including leukemias, lymphomas, multiple myeloma, myelodysplastic syndromes, and other hematological diseases.

Differentiator

Problem solved

Functional benefit

Brands

• Instituto Merula Steagall: Named institute honoring Merula Steagall, co-initiator of Abrale and the TJCC movement, focused on awards and recognition for oncology projects.
• Merula Steagall Awards
• Observatório de Oncologia
• Onco TeleInterconsulta
• Onco Ensino
• Projeto Dodói
• Rede Alianza Latina

Products and services

• Nutritional Counseling

Quantifiable outcome

• Free services provided to all blood cancer patients in Brazil without distinction
• +2 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Ten partnerships are on record, tiered core, major and minor.

• Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH)coreStrategic or Co-development PartnerStrategic partnership with ABHH for advocacy and policy work. Joint meetings with Ministry of Health representatives to discuss access to BCR-ABL testing, bone marrow transplant expansion, PCDT updates, and medication supply. Collaboration on multiple health policy initiatives including public consultations and healthcare system improvement.
• Movimento Todos Juntos Contra o Câncer (TJCC)coreStrategic or Co-development PartnerCo-founded and co-organizes the Todos Juntos Contra o Câncer (TJCC) movement, which organizes the annual TJCC Congress. The movement brings together healthcare organizations, patient groups, and professionals to advocate for improved cancer care policies in Brazil.
• Instituto Nacional do Câncer (INCA)majorStrategic or Co-development PartnerPartnership with INCA for monitoring data and research on blood cancers. Collaboration on myeloma multiple data studies and healthcare policy advocacy in the Brazilian public health system.
• Associação Brasileira de Talassemia (Abrasta)majorStrategic or Co-development PartnerJoint advocacy activities with Abrasta including joint supporter recognition events and coordinated participation in public health policy forums such as CONITEC consultations.
• Union for International Cancer Control (UICC)coreStrategic or Co-development PartnerActive member of UICC, participating in international cancer control efforts and global advocacy for improved cancer care policies.
• AshokaminorStrategic or Co-development PartnerInternational fellowship organization supporting social entrepreneurs; Abrale founders have Ashoka fellowship connections.
• Rede Alianza LatinamajorStrategic or Co-development PartnerLatin American alliance of patient organizations working together on blood cancer advocacy and support across the region.
• Observatório de OncologiamajorStrategic or Co-development PartnerProject partner for cancer data monitoring and research, including studies on mortality patterns among health plan users and blood cancer epidemiology.
• Hemorio (Rio de Janeiro)majorStrategic or Co-development PartnerPartnership with Hemorio hematology institute in Rio de Janeiro for patient advocacy, BCR-ABL testing access initiatives, and healthcare policy work at state level.
• International Coalitions (ALAN, MPN Advocates Network, Lymphoma Coalition, MDS Alliance, CML Advocates Network)coreStrategic or Co-development PartnerMember of multiple international disease-specific coalitions including: ALAN (CLL), MPN Advocates Network, Lymphoma Coalition, MDS Alliance, CML Advocates Network. Active participation in global advocacy efforts for blood cancer patients.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• ALAN - Acute Leukemia Advocates Network: Global network dedicated to acute leukemia patient advocacy. Abrale is an active member, and the organizations share disease focus, advocacy methodology, and international collaboration model.
• MPN Advocates Network: Global network for myeloproliferative neoplasms patient organizations, of which Abrale is a member. Comparable in disease focus (MPN), advocacy orientation, and international collaboration model.
• Instituto Oncoguia: Brazilian patient advocacy nonprofit focused on cancer patients broadly. Comparable in geographic scope (Brazil), operating model (free services, policy advocacy), and target audience (cancer patients and caregivers navigating the healthcare system).
• Lymphoma Coalition: Global network of lymphoma patient organizations of which Abrale is an active member. Directly comparable in disease focus (lymphoma), advocacy orientation, and member-driven model, though operating at global vs. national level.
• CML Advocates Network: Global leukemia-focused patient advocacy network. Abrale is an active member and partner. Comparable in disease specialization (CML), advocacy model, and educational resource development.
• Leukemia & Lymphoma Society (LLS): The largest US-based nonprofit dedicated to blood cancer research, education, and patient support. Highly comparable in mission (blood cancer patient advocacy and free services) and service mix (navigation, financial assistance, education), though at materially larger scale.
• Abrasta - Associação Brasileira de Talassemia: Brazilian nonprofit focused on a specific rare blood disease (thalassemia) with similar operating model: free patient services, public policy advocacy (including joint Conitec consultations with Abrale), and national reach. Direct co-advocacy partner of Abrale.
• MDS Alliance: International alliance of myelodysplastic syndromes patient organizations. Abrale is an active member, providing MDS-specific advocacy and education comparable in mission, disease focus, and member-based model.

Broad incumbents

• American Cancer Society: The largest US cancer advocacy and research nonprofit. Overlaps with Abrale on patient support, education, and policy advocacy but operates at vastly larger scale and across all cancers rather than specializing in blood cancers.
• Macmillan Cancer Support: Major UK cancer patient support charity providing free services (information, financial guidance, emotional support) comparable to Abrale's model but operating nationally in the UK across all cancer types with much larger funding base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/abraleoficial
• YouTubeyoutube.com/channel/UC7u3yc5HoS_fpMgD7dTkqSg
• Facebookfacebook.com/abrale
• Instagraminstagram.com/abraleoficial
• LinkedInlinkedin.com/company/abraleoficial

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Abrale - Associação Brasileira De Câncer Do Sangue